Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
OrdoPass is a SaaS/enterprise software platform for medical prescription routing. The captured text positions it as a platform to “securely create, share, and deliver prescriptions,” with separate login portals for doctors and pharmacists/pharmacies. Doctors can access their own dashboard, while pharmacists can enter a pharmacy workspace, indicating that the product is built around electronic prescription collaboration between healthcare providers and pharmacies.
Based on the disclosed information, the core modules include prescription creation, prescription sharing, prescription delivery/dispensing, as well as a doctor-side dashboard and a pharmacy-side workspace. Its main differentiator is role-based access: doctors generate prescriptions, while pharmacies receive and fulfill them. This model can help reduce paper-based prescription handoffs and improve prescription traceability. However, the page does not describe more detailed capabilities such as prescription validation, patient management, drug catalogs, notifications, history records, audit logs, or similar features.
The public page does not disclose any plans, pricing, free tier, trial policy, or payment methods. Doctors and pharmacies without an account need to contact the service by phone at +221 78 929 92 04, suggesting that onboarding may be sales-led or manually provisioned. There is also no mention of third-party integrations, APIs, developer documentation, or connectivity with hospital information systems or pharmacy systems.
The page explicitly describes it as a secure platform, but does not provide further details on data encryption, access control, medical data compliance, privacy policy, auditing, or data storage location. The deployment model is also not disclosed, so it is unclear whether it is a pure cloud SaaS product, a private deployment, or a hybrid setup. For a medical prescription system, these are key points that organizations must verify before procurement.
Its strengths are a clear positioning, well-defined user roles, coverage of the prescription workflow from doctor to pharmacy, and a direct contact channel. Its weaknesses are the limited public information and the lack of detail on pricing, compliance, integrations, permissions, and service support. It is best suited for clinics, doctor groups, and pharmacies within its service region that want to digitize prescription routing and begin with an initial consultation or evaluation.
Access from China is unknown, and the page does not indicate a focus on the Chinese market, Chinese-language support, or cross-border payments. If used in a Chinese healthcare setting, key considerations would include local medical compliance, drug regulation, prescription circulation policies, and integration with local systems. In most cases, local internet hospital platforms, electronic prescription circulation solutions, or pharmacy SaaS products should be evaluated first.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on ordopass.com official site.
ordopass.com is an France SaaS provider. TG4G tracks its product information, an overall rating of 5.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach ordopass.com directly.